During the past decade, Umhat Kaspela conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Umhat Kaspela" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Pfizer" with 2 trials sponsored, "Gedeon Richter Plc." with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "KBP Biosciences" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Umhat Kaspela" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Umhat Kaspela" are "Arthritis, Psoriatic" (3 trials), "Rheumatoid Arthritis" (2 trials), "Chronic Kidney Diseases" (1 trials), "Osteoarthritis, Hip" (1 trials) and "Osteoarthritis, Knee" (1 trials). Many other conditions were trialed in "Umhat Kaspela" in a lesser frequency.

Most popular intervention types in "Umhat Kaspela" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Guselkumab" (3 trials), "Filgotinib" (1 trials), "Filgotinib placebo" (1 trials) and "GS-9876" (1 trials). Other intervention names were less common.

The vast majority of trials in "Umhat Kaspela" are 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Umhat Kaspela". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Umhat Kaspela, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Umhat Kaspela, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".